Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg
- 22 January 2025 - 1 mins read
The purpose of this study is to demonstrate the pharmacodynamic equivalence of triptorelin pamoate (Pamorelin® LA 11.25 mg), applied either IM or SC, in terms of the area under the curve [AUC1-85day] for serum testosterone in patients with advanced prostate cancer.
22 January 2025
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
22 January 2025
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
22 January 2025
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
22 January 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
22 January 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
22 January 2025
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
22 January 2025
1 mins read
Dysport® Adult Lower Limb Spasticity Study
22 January 2025
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
22 January 2025
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
22 January 2025
1 mins read